Manufacturer record
OCT Therapies and Research Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by OCT Therapies and Research Pvt. Ltd (Maharashtra) were declared Not of Standard Quality in January 2019. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 1, Octt Skin Serum (exp Jan 2019). CDTL Mumbai (CDSCO lab) found it not of standard quality: Specific Gravity. Listed in the January 2019 alert.
Records by type
2 records linked to OCT Therapies and Research Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Octt Skin Serum | Batch 1Mfg Jul 2017 · Exp Jan 2019 | Specific GravityOther | CDTL MumbaiCDSCO lab | Jan 2019 |
| Octt Hair Serum | Batch 3Mfg Feb 2018 · Exp Aug 2019 | Specific GravityOther | CDTL MumbaiCDSCO lab | Jan 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.